The following is a summary of “Identification of molecular clusters and a risk prognosis model for diffuse large B-cell ...

Mitochondrial diseases, arising from mutations in mitochondrial DNA (mtDNA), are a diverse group of disorders that lead to ...

A surge of generics, biosimilars, and innovative therapies is expected in 2025, addressing conditions from cancer to chronic ...

Discover the best food pairings to boost nutrient absorption and get more benefits from the healthy meals you're already ...

A new study published in the Turkish Journal of Hematology showed that ferric carboxymaltose may raise hemoglobin and ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

The Turner Twins did a new health experiment. This time, Ross and Hugo compared meat and vegan diets. They checked how these ...

Healthcare pioneer Laura Shawver, Ph.D. appointed Chair of the Board and industry veteran Roy Baynes M.D., Ph.D. appointed as independent, non-exe ...

AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Gordon D. McLaren, MD, professor emeritus at UC Irvine Medical Center, is a specialist in the field of hematology and oncology, where he is known for his ...

This useful study provides incomplete evidence that TANGO2 homologs, including HRG-9 and HRG-10, are not heme chaperones but play a role in cellular bioenergetics and oxidative stress homeostasis.